We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Inspection Details Now Required in Premarket Submissions: EMA
Inspection Details Now Required in Premarket Submissions: EMA
Sponsors of brand, generic and biosimilar drugs applying for marketing authorization through the EU’s centralized procedure must begin including facility inspection information in their applications.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor